Who Benefits From Chemoradiotherapy in Early-Stage OPSCC?

In patients with T1-2 oropharyngeal cancer and low-volume neck disease, adding chemotherapy to radiotherapy does not improve overall survival, according to a new study. Medscape Medical News

Read the full article on medscape.com